Corporate | 23 October 2015 17:30
MeVis Medical Solutions AG: Domination and profit and loss transfer agreement registered with the Commercial Register
|
DGAP-News: MeVis Medical Solutions AG / Key word(s): Miscellaneous
Bremen, November 23, 2015 – The MeVis Medical Solutions AG announces today that the domination and profit and loss transfer agreement concluded on August 10, 2015 between the VMS Deutschland Holdings GmbH as the controlling company and MeVis Medical Solutions AG as the controlled company has been registered with the Commercial Register of the Bremen Local Court on October 20, 2015 and has thus become legally effective. The registration in the Commercial Register has been published by the Bremen Local Court on October 21, 2015. The shareholders of the MeVis Medical Solutions AG already approved the domination and profit and loss transfer agreement with a large majority in the extraordinary general meeting on September 29, 2015. Under the domination and profit and loss transfer agreement and upon request of each outside shareholder the VMS Deutschland Holdings GmbH is obliged to acquire MeVis shares against a cash settlement payment in the amount of EUR 19.77 per MeVis share. Optionally, the VMS Deutschland Holdings GmbH guarantees the outside shareholders of MeVis Medical Solutions AG, who chose not to accept the settlement payment offer, for the duration of the domination and profit and loss transfer agreement an annual compensation payment for each MeVis Medical Solutions AG fiscal year and each registered share in MeVis Medical Solutions AG, representing a pro rata amount of the share capital of EUR 1.00 per share, in the amount of EUR 1.13 gross / EUR 0.95 net.
2015-10-23 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| Language: | English | |
| Company: | MeVis Medical Solutions AG | |
| Caroline-Herschel-Str. 1 | ||
| 28359 Bremen | ||
| Germany | ||
| Phone: | +49 421 224 95 0 | |
| Fax: | +49 421 224 95 999 | |
| E-mail: | ir@mevis.de | |
| Internet: | http://www.mevis.de | |
| ISIN: | DE000A0LBFE4 | |
| WKN: | A0LBFE | |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart | |
| End of News | DGAP News Service |
|
|
|
405179 2015-10-23
|